1. Market Research
  2. > Pathology
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030 ##.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • United Kingdom

Peripheral T-Cell Lymphoma Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

Anaplastic Large Cell Lymphoma (ALCL) ##. ##. ##.

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • United States

Brain Cancer: Epidemiology Forecast to 2027

  • $ 3995
  • October 2018
  • 32 pages

Brain Cancer: Epidemiology Forecast to 2027 Summary Epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an ...

  • Brain Cancer
  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom

Hodgkin Lymphoma - Epidemiology Forecast to 2029

  • $ 3995
  • June 2020
  • 44 pages

LYMPHOMA WAS DEFINED BY THE ICD-## CODES C##-C##, C##, C##, AND C##.

  • Cancer
  • Hospital
  • Lymphoma
  • United Kingdom
  • Forecast

Market Spotlight: NHL: Peripheral T-cell lymphoma (PTCL)

  • $ 1318
  • April 2020
  • 54 pages

This Market Spotlight report covers the Peripheral T-Cell Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, probability of success, patent information, a 10-yea ...

  • Cancer
  • Lymphoma
  • United Kingdom
  • United States

Coronavirus Disease 2019 - Epidemiology Analysis and Forecast - June 2020

  • $ 1995
  • June 2020
  • 38 pages

Coronavirus Disease 2019: Epidemiology Analysis and Forecast - June 2020 June ##, 2020 GDHCHT## Copyright @ GlobalData PLC.

  • Epidemiology
  • Lymphoma
  • Pharmaceutical
  • United Kingdom
  • United States

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • September 2018
  • 162 pages

It is indicated for adult patients with R/ R DLBCL and primary mediastinal large B-cell lymphoma (PMBCL).

  • Cancer
  • Lymphoma
  • Oncology
  • Pharmaceutical
  • United Kingdom

2020 UK Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 575 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demand

2020 UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 527 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • Demand

2020 UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 527 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • Forecast

2020 UK Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 575 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demand

Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 15900
  • June 2019
  • 700 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Japan
  • United Kingdom
  • Demand

2020 UK Hematology and Flow Cytometry Lab and POC Market: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 1850
  • April 2020
  • 250 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • United Kingdom
  • Demand
  • Market Shares

2024 Europe Hematology and Flow Cytometry Analyzers and Reagents Market: France, Germany, Italy, Spain, UK

  • $ 9500
  • July 2020
  • 450 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Europe
  • United Kingdom
  • Demand

UK Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 527 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • United Kingdom

UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 527 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Forecast

2020 Europe Hematology and Flow Cytometry Lab and POC Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

  • $ 7500
  • April 2020
  • 450 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Molecular Diagnostics
  • United Kingdom
  • Market Shares

2018 Global Hematology and Flow Cytometry Market: US, Europe, Japan--Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 15900
  • June 2018
  • 700 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Molecular Diagnostics
  • United Kingdom
  • Demand

UK Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 575 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demand

Pancreatic Cancer: Epidemiology Forecast to 2026

  • $ 3995
  • April 2018
  • 42 pages

Pancreatic Cancer: Epidemiology Forecast to 2026 Summary Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries ...

  • Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Pathology
  • United Kingdom
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on